Virax Biolabs Grp Ltd (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Virax Biolabs Group Ltd - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Virax Biolabs Group Ltd - Ordinary Shares - Class A
Rating: 0.95450
Author: Trendlyne DVM scores

about

Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and service...

0.13 0.00 (0.00%)

89.17% Fall from 52W High

1.7M

XNAS Volume

XNAS 04 May, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

16.5 / 100

Technically Bearish

21.7 / 100

1Yr Price target upside is 669%

1 analysts

Virax Biolabs Grp Ltd (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Virax Biolabs Grp Ltd (Class A) Live Stock Price Today, Share Analysis and Chart

Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and service...

89.17% Fall from 52W High

SWOT Analysis

Virax Biolabs Grp Ltd (Class A) Live Price Chart